The R-E-V-I-V-A-L Study

NCT06992674 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Vestibular Migraine

Interventions

DRUG: Rimegepant
DRUG: Placebo

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University